A comparative analysis of the decoupling effects in a magnetic forming beryllium coil assembly

Digital computer for determining currents and forces in magnetic forming beryllium coil assembl

Improving induction of labour for women through the development of a new pathway

Background: Although induction of labour is a safe procedure for the pregnant woman at term, the process is not without risk. In recognition of these challenges associated with induction, an audit of local service provision was undertaken. Aim: To identify problems with the existing induction service. Methods: This was a retrospective analysis of women’s notes from May to December 2016. All patient records of pregnant women who had received induction during this time (n=870) were examined, as well as complaints and feedback received by the service. Findings: The audit identified several issues that would need to be addressed if the service was to be improved. These concerns were divided into two groups: the pregnant woman’s perspective and service provision issues. Conclusion: A new induction of labour pathway was created that aimed to address some of the concerns identified by the audit, and improve the care that women received. A further audit was conducted to assess the improvement in care as a result

A study of intense magnetic fields for high energy forming and structural assembly Interim report

Determination of maximum force on static sheet of aluminum subjected to magnetic field of hammer coi

Development of a valid mathematical formula or group of formulas to establish within an accuracy of 5 percent the inductance audio range resulting in beryllium coil assemblies Final report

Mathematical formulas to determine net inductance in audio range of both hammer coil and cryogenic sealing coi

Application of EREP imagery to fracture-related mine safety hazards in coal mining and mining-environmental problems in Indiana

The author has identified the following significant results. This investigation evaluated the applicability of a variety of sensor types, formats, and resolution capabilities to the study of both fuel and nonfuel mined lands. The image reinforcement provided by stereo viewing of the EREP images proved useful for identifying lineaments and for mined lands mapping. Skylab S190B color and color infrared transparencies were the most useful EREP imagery. New information on lineament and fracture patterns in the bedrock of Indiana and Illinois extracted from analysis of the Skylab imagery has contributed to furthering the geological understanding of this portion of the Illinois basin

Working on wellness (WOW): a worksite health promotion intervention programme

Background: Insufficient PA has been shown to cluster with other CVD risk factors including insufficient fruit and vegetable intake, overweight, increased serum cholesterol concentrations and elevated blood pressure. This paper describes the development of Working on Wellness (WOW), a worksite intervention program incorporating motivational interviewing by wellness specialists, targeting employees at risk. In addition, we describe the evaluation the effectiveness of the intervention among employees at increased risk for cardiovascular disease. Methods: The intervention mapping (IM) protocol was used in the planning and design of WOW. Focus group discussions and interviews with employees and managers identified the importance of addressing risk factors for CVD at the worksite. Based on the employees preference for individual counselling, and previous evidence of the effectiveness of this approach in the worksite setting, we decided to use motivational interviewing as part of the intervention strategy. Thus, as a cluster-randomised, controlled control trial, employees at increased risk for CVD (N = 928) will be assigned to a control or an intervention group, based on company random allocation. The sessions will include motivational interviewing techniques, comprised of two face-to-face and four telephonic sessions, with the primary aim to increase habitual levels of PA. Measures will take place at baseline, 6 and 12 months. Secondary outcomes include changes in nutritional habits, serum cholesterol and glucose concentrations, blood pressure and BMI. In addition, healthcare expenditure and absenteeism will be measured for the economic evaluation. Analysis of variance will be performed to determine whether there were significant changes in physical activity habits in the intervention and control groups at 6 and 12 months. Discussion: The formative work on which this intervention is based suggests that the strategy of targeting employees at increased risk for CVD is preferred. Importantly, this study extends the work of a previous, similar study, Health Under Construction, in a different setting. Finally, this study will allow an economic evaluation of the intervention that will be an important outcome for health care funders, who ultimately will be responsible for implementation of such an intervention. Trial registration: United States Clinical Trails Register NCT 01494207

Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis

Background: Zenpep (APT-1008) is a pancreatic enzyme product for the treatment of exocrine pancreatic insufficiency (EPI) associated with cystic fibrosis (CF). Methods: Zenpep and Kreon, both containing 25,000 lipase units, were compared in a randomised, double-blind, crossover, non-inferiority study for CF-associated EPI in patients aged ≥12 years. Patients on a standardised diet and stabilised treatment were randomised to two treatment sequences: Zenpep/Kreon or Kreon/Zenpep. The primary efficacy endpoint was the coefficient of fat absorption over 72 h (CFA-72 h). Results: 96 patients (mean age 19.2 years, 60.4% males) were randomised with 83 completers of both sequences comprising the efficacy population. Zenpep demonstrated non-inferiority and equivalence to Kreon in fat absorption (LS mean CFA-72 h: Zenpep, 84.1% [SE 1.1] vs. Kreon, 85.3% [SE 1.1]; p = 0.297). Safety and tolerability were similar. Conclusions: Zenpep is comparable with Kreon in efficacy and safety for the treatment of adolescents and adults with CF-associated EPI. NCT0164139